Production of influenza virus in cell cultures for vaccine preparation.

Influenza virus strains of different types for use as an inactivated vaccine have been successfully grown in different cell lines. Increasing titres were obtained with BHK-21/BRS, VERO and MDCK cells. Cultures in stationary flasks, in spinner cultures or in large bioreactor systems were tested and the optimal conditions were studied. MDCK cells grown in serum-free medium before and during the virus production phase were found to yield high titres in the presence of trypsin. Satisfactory results were obtained with egg-adapted strains of human and equine origin as well as with strains just isolated from human patients without any further passages in eggs or cell culture.

[1]  O. Merten,et al.  A simple serum-free freezing medium for serum-free cultured cells. , 1995, Biologicals : journal of the International Association of Biological Standardization.

[2]  J. Oxford,et al.  Direct isolation in eggs of influenza A (H1N1) and B viruses with haemagglutinins of different antigenic and amino acid composition. , 1991, The Journal of general virology.

[3]  P. Perrin,et al.  An experimental rabies vaccine produced with a new BHK-21 suspension cell culture process: use of serum-free medium and perfusion-reactor system. , 1995, Vaccine.

[4]  J. Oxford,et al.  Structural changes in the haemagglutinin which accompany egg adaptation of an influenza A(H1N1) virus. , 1987, Virology.

[5]  R. Pyhälä,et al.  Egg-grown and tissue-culture-grown variants of influenza A (H3N2) virus with special attention to their use as antigens in seroepidemiology , 1987, Epidemiology and Infection.

[6]  N. Cox,et al.  Comparison of 10 influenza A (H1N1 and H3N2) haemagglutinin sequences obtained directly from clinical specimens to those of MDCK cell- and egg-grown viruses. , 1993, The Journal of general virology.

[7]  J. Oxford,et al.  Serological studies with influenza A(H1N1) viruses cultivated in eggs or in a canine kidney cell line (MDCK). , 1987, Bulletin of the World Health Organization.

[8]  R. Webster,et al.  Extensive heterogeneity in the hemagglutinin of egg-grown influenza viruses from different patients. , 1989, Virology.

[9]  P. J. Radlett.  The use of BHK suspension cells for the production of foot and mouth disease vaccines. , 1987, Advances in biochemical engineering/biotechnology.

[10]  J. B. Griffiths,et al.  Animal Cell Technology: Products of Today, Prospects for Tomorrow , 1994 .

[11]  B.G.D. Bödeker,et al.  PRODUCTION OF RECOMBINANT FACTOR VIII FROM PERFUSION CULTURES: II. LARGE-SCALE PURIFICATION , 1994 .

[12]  B. Fanget,et al.  Thousand litre scale microcarrier culture of Vero cells for killed polio virus vaccine. Promising results. , 1983, Developments in biological standardization.

[13]  J. Oxford,et al.  Influenza A (H1N1) vaccine efficacy in animal models is influenced by two amino acid substitutions in the hemagglutinin molecule. , 1989, Virology.

[14]  R. Telling,et al.  Growth of a Cloned Strain of Hamster Kidney Cells in Suspended Cultures and their Susceptibility to the Virus of Foot-and-Mouth Disease , 1962, Nature.